The Company's Annual and Special General Meeting of Shareholders is confirmed for Thursday, October 30, 2008 at 11:30 AM ET (8:30 AM Pacific). Due to the proximity of the earnings conference call, there will be no management update at the Annual and Special General Meeting of Shareholders; and therefore, the meeting will not be made available via webcast or conference call.

    Dial information for the earnings call on November 6, 2008 is as follows:

    North America (toll-free): (866) 383-7998
    International: (617) 597-5329
    Enter passcode: 11247654

A live webcast of the earnings conference call will be available to all interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the conference call on November 6 at approximately 8:00 AM ET (5:00 AM Pacific).

A replay archive of the conference call will be available until November 13, 2008.

    Replay information is as follows:

    North America: (888) 286-8010
    International: (617) 801-6888
    Enter passcode: 75181409

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP) please visit our website at www.angiotech.com.

SOURCE Angiotech Pharmaceuticals, Inc.

* Q3 GAAP loss per share $7.31 from continuing operations

* Q3 adjusted loss per share from continuing operations $0.05

* Says no assurance that it will have adequate liquidity, capital resources to

satisfy our financial obligations in 2009 and beyond

* Says may be forced to explore alternative funding sources through debt,

equity or other public or private securities offerings

* Says may also pursue certain reorganization, restructuring or other strategic

alternatives

((Toronto Newsroom, 416-941-8100)) (For more news about Angiotech Pharmaceuticals Inc, click here)

COPYRIGHT

Copyright Thomson Reuters 2008. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

MMMM

Expected next investor conference call information:
Conference Call Date: 11/6/2008
Conference Call Time: 11:00 AM
Conference Call URL: http://www.angiotech.com/investors/events-webcasts/

The Angiotech Pharmaceuticals, Inc. Annual and Special General Meeting will also be available via a live webcast in the Investors section of Angiotech's website at http://www.angiotech.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.

SOURCE Angiotech Pharmaceuticals, Inc.